LifeSci Capital analyst Cory Jubinville initiated coverage of Mereo BioPharma (MREO) with an Outperform rating and $10 price target
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.